Prolactin related symptoms during risperidone maintenance treatment: results from a prospective, multicenter study of schizophrenia
… antipsychotics or the second generation antipsychotics … differences, a Hochberg adjustment
for multiple comparisons … related side effects may comprise important concerns in patients …
for multiple comparisons … related side effects may comprise important concerns in patients …
[HTML][HTML] Prolactin level changes according to atypical antipsychotics use: a study based on clinical data warehouse
S Kim, JH Jeong, YH Um, TW Kim, H Seo… - Clinical …, 2023 - ncbi.nlm.nih.gov
… the use of antipsychotic drugs in patients through the Clinical … Hyper-prolactinemia inhibits
the secretion of luteinizing hormone (… In an open-label study on prolactin elevation of atypical …
the secretion of luteinizing hormone (… In an open-label study on prolactin elevation of atypical …
Hyperprolactinaemia in the context of psychiatry
K Romain, S Fynes-Clinton, D Harmer… - BJPsych Advances, 2021 - cambridge.org
… hyperprolactinaemia and preferred units of measurement differ across … Comparatively, of
the second-generation antipsychotics the … to relieve troubling symptoms in patients prescribed …
the second-generation antipsychotics the … to relieve troubling symptoms in patients prescribed …
Antipsychotic medication for women with schizophrenia spectrum disorders
BA Brand, YRA Haveman, F De Beer… - Psychological …, 2022 - cambridge.org
… on the differences in the action of antipsychotic medication in … Sex, ethnicity, and antipsychotic
medication use in patients with … exposure to secondgeneration antipsychotics given with …
medication use in patients with … exposure to secondgeneration antipsychotics given with …
[HTML][HTML] Prolactin level in patients with first episode schizophrenia treated for one year with atypical antipsychotics
… 2 weeks during the preceding year and less than 6 weeks … values of prolactinemia at baseline
both in men and in women … Analysis of a randomized open-label 1 year study. doi: 10.1016/…
both in men and in women … Analysis of a randomized open-label 1 year study. doi: 10.1016/…
[HTML][HTML] … clinical effect of alpha-lipoic acid administration in schizophrenic subjects stabilized with atypical antipsychotics: A 12-week, open-label, uncontrolled study
F Iannuzzo, GA Basile, D Campolo, G Genovese… - Current Research in …, 2022 - Elsevier
… second generation antipsychotics can induce metabolic side … and dyslipidaemia in patients
treated with atypical antipsychotics … study, ALA significantly reduced prolactinaemia after 12 …
treated with atypical antipsychotics … study, ALA significantly reduced prolactinaemia after 12 …
Overview of short-term and long-term safety of brexpiprazole in patients with major depressive disorder and inadequate response to antidepressant treatment
JC Nelson, P Zhang, A Skuban… - Current Psychiatry …, 2016 - ingentaconnect.com
… medication such as a second-generation antipsychotic [4]. … studies; the incidence of
hyperprolactinemia in the long-term studies … in patients from the long-term open-label study by …
hyperprolactinemia in the long-term studies … in patients from the long-term open-label study by …
[HTML][HTML] Lumateperone for the Treatment of Schizophrenia
A Edinoff, N Wu, C deBoisblanc… - Psychopharmacology …, 2020 - ncbi.nlm.nih.gov
… can cause myriad side effects, most prominently prolactinemia and extrapyramidal side …
symptoms and EPS in patients with schizophrenia. The year-long open-label study 303 was also …
symptoms and EPS in patients with schizophrenia. The year-long open-label study 303 was also …
Drug safety evaluation of aripiprazole in bipolar disorder
A Cuomo, B Beccarini Crescenzi… - Expert Opinion on …, 2019 - Taylor & Francis
… Hypo-prolactinemia may be related to sperm abnormalities … , especially in patients with risk
factors for TD such as female … A 46-week open-label extension study [Citation65] evaluated …
factors for TD such as female … A 46-week open-label extension study [Citation65] evaluated …
A 52-week, randomized, open-label study of aripiprazole versus blonanserin in the treatment of Japanese schizophrenia patients
A Katsuki, H Hori, K Atake, R Igata… - Clinical …, 2017 - jstage.jst.go.jp
… (EPS) and hyperprolactinemia than typical antipsychotics [1]. … improving negative symptoms
in patients with schizophrenia [… comparisons of metabolic side effects of second generation …
in patients with schizophrenia [… comparisons of metabolic side effects of second generation …